Investor mix
23 investors on record; lead investors include ShenZhen GTJA Investment Group, Xicheng Jinrui, Decheng Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 43% |
| Private equity | 8 | 35% |
| Angel & family office | 1 | 4% |
| Other / undisclosed | 4 | 17% |
Developer of small molecule therapeutics for the treatment of cancer
23 investors on record; lead investors include ShenZhen GTJA Investment Group, Xicheng Jinrui, Decheng Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 43% |
| Private equity | 8 | 35% |
| Angel & family office | 1 | 4% |
| Other / undisclosed | 4 | 17% |